Wells Fargo’s Vigil Neuroscience VIGL Stock Holding History

Wells Fargo’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-615	Closed	-$4.89K	–	7417
2025 Q2	$4.89K	Buy	+615	New	+$2.76K	﹤0.01%	6093
2024 Q2	–	Sell	-5,655	Closed	-$19.3K	–	7497
2024 Q1	$19.3K	Buy	5,655 +729	+15%	+$2.28K	﹤0.01%	5586
2023 Q4	$16.6K	Buy	4,926 +974	+25%	+$5.01K	﹤0.01%	5700
2023 Q3	$21.3K	Sell	3,952 -2,144	-35%	-$14.8K	﹤0.01%	5569
2023 Q2	$57.3K	Buy	6,096 +6,010	+6,988%	+$56.8K	﹤0.01%	5366
2023 Q1	$842	Buy	86 +1	+1%	+$11	﹤0.01%	6431
2022 Q4	$1.06K	Buy	85 +31	+57%	+$381	﹤0.01%	6168
2022 Q3	$0	Buy	54 +7	+15%	+$51	﹤0.01%	7440
2022 Q2	$0	Sell	47 -1,418	-97%	-$5.6K	﹤0.01%	7565
2022 Q1	$10K	Buy	+1,465	New	+$19.3K	﹤0.01%	6274

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Wells Fargo's VIGL Position: Q3 2025 in Review

Wells Fargo sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 615 shares — an estimated $4.89K sold.

Wells Fargo first reported a position in VIGL in Q1 2022 and held it in 10 quarters. The position peaked at $57.3K in Q2 2023. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Wells Fargo reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Wells Fargo sold 615 Vigil Neuroscience shares in Q3 2025, an estimated $4.89K.
Wells Fargo first reported a position in Vigil Neuroscience in Q1 2022 and held it in 10 quarters.
Wells Fargo's Vigil Neuroscience position peaked at $57.3K in Q2 2023.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Wells Fargo's 13F filing for Q3 2025, filed 13 Nov 2025.